Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms

Journal of Vascular Surgery

Volumn 34, Issue 2, 2001, Pages 212-215

  Lindholt, Jes S ^a   Ashton, Hilary A ^b   Scott, R Alan P ^b  

^a VIBORG HOSPITAL   (Denmark)

^b ST RICHARD S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; BACTERIAL INFECTION; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HUMAN; MALE;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HUMANS; MALE;

EID: 0035430819     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.115816     Document Type: Article

References (38)

1. Saikku P, Leinonen M, Matilla K. Serological evidence of an association of a novel chlamydia, TWAR, with chronical coronary heart disease and acute niyocardial infarction. Lancet 1988;2:983-6.
2. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MK, Manninen V, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992;116:273-8.
3. Leinonen M, Linnanmäki E, Matilla K, Nieminen MS, Valtonen V, Leirisalo-Repo M, et al. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog 1990;9:67-73.
4. Thom DH, Wang S, Grayston JT, Siscovick DS, Stewart DK. Chlamydia pneumoniae stain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991;11: 547-51.
5. Thom DH, Grayston JT, Siscovick DS, Wang S, Weiss NS, Darling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary disease. JAMA 1992; 268:68-72.
6. Linnanmäki E, Leinonen M, Matilla K, Nieminen MS, Valtonen V, Saikku F. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993;87:1130-4.
7. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in arteriosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-9.
8. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992;82:158-61.
9. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A 1995;92:6911-4.
10. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, et al. Increased incidence of Chlamydia pneumoniae species within the coronary arteries of patients with symptomatic atherosclerosis versus other forms of cardiovascular disease. J Am Coll Cardiol 1996;27:1555-61.
11. Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995;92:3397-400.
12. Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic atherosclerotic lesions by immunocytochemical stain. Arterioscler Thromb 1993;13:1501-4.
13. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996;49:102-6.
14. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B, for the ROXIS Study Group. Randomized trial of roxithromycin in non-Q-wave coronary syndromes: Roxis pilot study. Lancet 1997;350:404-7.
15. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-7.
16. Whiteman M, Halliwell B. Prevention of peroxynitrite dependent tyrosine nitration and inactivation of alpha-1-antiprotease by antibiotics. Free Radic Res 1997;26:49-56.
17. Lindholt JS, Vammen S, Lind I, Fasting H, Hennerg EW. IgA antibodies against Chlamydia pneumoniae are associated to increased expansion of small abdominal aortic aneurysms. Br J Surg 1999;86: 634-8.
18. Scott RAP, Ashton HA, Kay DN. Abdominal aortic aneurysm in 4237 screened patients: prevalence, development and management over six years. Br J Surg 1991;78:1122-5.
19. Wang SP, Grayston JT. Immunological relationship between genital TRIC, lymphogranuloma venereum and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol 1970;70:367-74.
20. Schacter J. Pathogenesis of chlamydial infections. Pathol Immunopathol Res 1989;8:206-20.
21. Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect 1992;25:27-35.
22. Grayston JT, Wang SP, Yeh LJ, Kuo CC. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis 1985;7:717-25.
23. Beatty WL, Byrne GI, Morrison RP. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol 1994;2:94-8.
24. Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990;161:618-25.
25. Aldous MB, Grayston JT, Wang SP, Foy HM. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979. J Infect Dis 1992;166:646-9.
26. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995;8:451-61.
27. Juvonen J. Chlamydia pneumoniae. Infection in abdominal aortic aneurysms and aortic valve stenosis. University of Oulu, Finland; 1997; ISBN 951-42-4600-4:1-76.
28. Lindholt JS, Heickendorff L, Fasting H, Henneberg EW. Serumelastin-peptides as predictor for the expansion of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 1997;14:12-6.
29. Sterpetti AV, Schultz RD, Feldhaus RJ, Cheng SE, Peetz DJ. Factors influencing enlargement of small abdominal aortic aneurysms. J Surg Res 1987;43:211-9.
30. Cronenwett J. Variables that affect the expansion rate and outcome of small abdominal aortic aneurysm. J Vasc Surg 1990;11:261-9.
31. Sterpetti AV, Schultz RD, Feldhaus RJ, Peetz DJ, Fasciano AJ, McGill JE. Abdominal aortic aneurysms in elderly patients. Selective management based on clinical status and aneurysmal expansion rate. Am J Surg 1985;150:772-6.
32. Bengtsson H, Nilsson P, Bergqvist D. Natural history of abdominal aortic aneurysm detected by screening. Br J Surg 1993;80:718-20.
33. Thomas PRS, Shaw JC, Ashton HA, Kay DN, Scott RAP. Accuracy of ultrasound in a screening program for abdominal aortic aneurysms. J Med Screen 1994;1:3-6.
34. Ellis M, Powell JT, Place J, Mills S, Wolfe J, Boultbee J, et al. The limitations of ultrasound in surveillance of small abdominal aortic aneurysms. In: Greenhaulgh RM, editor. The causes and management of aneurysms. London: Saunders; 1990. p. 117-22.
35. Pedersen OM, Aslaksen A, Vik-Mo H. Ultrasound measurement of the luminal diameter of the abdominal aorta and iliac arteries in patients without vascular disease. J Vasc Surg 1993;17:596-601.
36. Scott RAP, Wilson NM, Ashton HA, Kay DN. Is surgery necessary for abdominal aortic aneurysm less than 6 cm in diameter? Lancet 1993;342:1395-6.
37. The UK Small Aneurysm Trial Participants. Mortality results for randomized controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 1998;352: 1649-55.
38. Lindhalt JS. Considerations and experiences of screening for abdominal aortic aneurysms [PhD Thesis]. Copenhagen: FADL's Forlag; 1998.